Enrolling 1,000 Patients

May 21, 2020

Enrolling 1,000 Patients

Clinical testing has begun on Gilead’s antiviral drug remdesivir coupled with baricitinib, an anti-inflammatory medicine. The enrollment of more than 1,000 participants is ongoing. In addition to supporting clinical trials, Yourway can also provide all ancillary materials needed during a trial, no matter how large the scale.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

Schedule a Meeting

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat

Hello! How can I help you?